Level of serum IL-33 and paraseptal emphysema in clove cigarette smoker with spontaneous pneumothorax: A case report

Hansell, 2008, Flieschner society: glossary of terms for thoracic imaging, Radiology, 246, 697, 10.1148/radiol.2462070712 Araki, 2015, Paraseptal emphysema:prevalence and distribution on CT and association with interstitial lung abnormalities, Eur. J. Radiol., 84, 1413, 10.1016/j.ejrad.2015.03.010 Sims, 2010, The IL-1 family:regulators of immunity, Nat. Rev. Immunol., 10, 89, 10.1038/nri2691 Gabryelska, 2019, IL-33 mediated inflammation in chronic respiratory diseases-understanding the role of the member of IL-1 superfamily, Frontiers in Immunity, 10, 692, 10.3389/fimmu.2019.00692 Keller, 2003, Pathophysiology and clasification of emphysema, Chest Surg Clin., 13, 589, 10.1016/S1052-3359(03)00092-9 Craig, 2017, Immune-mediated inflmmation in the pathogenesis of emphysema:insights from mouse models, Cell Tissue Res., 367, 591, 10.1007/s00441-016-2567-7 Pauwels, 2004, Burden and clinical features of chronic obstructive pulmonary disease (COPD), Lancet, 363, 613, 10.1016/S0140-6736(04)16855-4 Grabiec, 2016, The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation, Semin. Immunopathol., 38, 409, 10.1007/s00281-016-0555-3 Sharafkhaneh, 2008, Pathogenesis of emphysema, Proc Am Thorac Soc, 5, 475, 10.1513/pats.200708-126ET Byers, 2019, Linking VEGF deficiency and IL-33 upregulation in chronic obstructive pulmonary disease, Am. J. Respir. Cell Mol. Biol., 61, 550, 10.1165/rcmb.2019-0175ED Lee, 2011, Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease, Proc Am Thorac Soc, 8, 512, 10.1513/pats.201102-018MW Pace, 2014, Cigarette smoke alters IL-33 expression and release in airway epithelial cells, Biochimica et Biophysica Acta, 1842, 1630, 10.1016/j.bbadis.2014.06.009 Lee, 2019, Cigarette smoke triggers IL-33 associated inflammation in a model of late-stage COPD, Am J Respir Cell Mol Biol, 61, 567, 10.1165/rcmb.2018-0402OC Xia, 2015, Increased IL-33 expression in chronic obstruction lung disease, Am. J. Physiol. Lung Cell Mol. Physiol., 308, L619, 10.1152/ajplung.00305.2014 IL-33 ELISA kit Elabscience Catalog No: E-EL-H2402. Accessed Jan 20, 2020. Paulauskaite, 2020, Investigating the role of IL-13 and soluble ST2 in pediatric atopic dermatitis, Our Dermatol Online, 11, 120, 10.7241/ourd.20202.2 Yalcin, 2019, Anti-IgE significantly changes circulating interleukine-25, vitamin-D, and interleukine-33 levels in patients with allergic asthma, Curr Pharm Design, 25, 1, 10.2174/1381612825666190930095725 Thomson, 2016, Novel approaches to the management of noneosinophilic asthma, Ther. Adv. Respir. Dis., 10, 211, 10.1177/1753465816632638 Zou, 2010, IL-33 induced inflammation exacerbated the development of chronic obstructive pulmonary disease through oxidative stress, Eur Rev Med Pharmacol Sci, 22, 1758 Shapiro, 1999, The macrophage in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 160, S29, 10.1164/ajrccm.160.supplement_1.9 Retamales, 2001, Amplification of inflammation in emphysema and its association with latent adenovirus infection, Am. J. Respir. Crit. Care Med., 164, 469, 10.1164/ajrccm.164.3.2007149 Barnes, 2003, Chronic obstructive pumonary disease:molecular and cellular mechanism, Eur. Respir. J., 22, 672, 10.1183/09031936.03.00040703 John, 2016, Loss of epithelial Gq and G11signaling inhibits TGFβ production but promotes IL-33-mediated macrophage polarisation and emphysema, Sci. Signal., 9, ra104, 10.1126/scisignal.aad5568